Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 15, 2009 (Vol. 29, No. 6)


  • Well-organized
  • None
I don’t believe that in the 12 years I’ve been doing Best of the Web I’ve ever covered or even seen a page from this university system with its unusual acronym. Standing as a shortened way of saying NorthEastern Ohio Universities Colleges of Medicine and Pharmacy, NEOUCOM (why not NEOUCOMP?) hosts a collection of impressively organized links spanning a wide range of medical topics—including anatomy/ embryology/development, brain, cloning/genetic engineering, diabetes, geronotology medical education, physiology, nephrology, and much more. Under each subheading, visitors will find links to books, journals, databases, audio/visuals, and other websites relevant to the topic. Someone has gone to a lot of trouble to pull all of this together and, best of all, to organize it in a fashion that makes access to the information trivial. Bravo! I wish more sites were as superbly organized as this one. Definitely worth a look-see.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »